Back to Results
First PageMeta Content
Federal Trade Commission / Government / United States antitrust law / Disgorgement / Jon Leibowitz / Robert Pitofsky / Sherman Antitrust Act / Damages / Law / Judicial remedies / Corporate crime / Consumer protection


Dissenting Statement of Commissioner Maureen K. Ohlhausen
Add to Reading List

Open Document

File Size: 69,66 KB

Share Result on Facebook

Company

Cardinal Health Inc. / Mylan Labs. / Syncor International / COMMISSIONER MAUREEN K. OHLHAUSEN CARDINAL HEALTH INC. / AbbVie Inc. / General Electric Co. / Perrigo Co. / See Cardinal Health Inc. / See PharmaRx Pharma / Geodax Technology Inc. / Cephalon Inc. / Mylan Labs Inc. / GE Healthcare Inc. / Hearst Trust / Bristol-Myers Squibb / Schine Chain Theatres Inc. / /

Country

United States / /

Event

Conference Call / M&A / Business Partnership / /

IndustryTerm

case law / generic pharmaceutical markets / antitrust law / radiopharmacy operator / /

Organization

Congress / UN Court / Supreme Court / US Federal Reserve / U.S. Chamber of Commerce / Antitrust Modernization Commission / Federal Trade Commission / Fashion Originators’ Guild of Am / /

Person

Thomas B. Leary / R. Bruce Josten / Sherman Act / Robert Pitofsky / Mozelle W. Thompson / Jon Leibowitz / Sheila F. Anthony / /

Position

Chairman / prosecutor / Exec. / Commissioner / /

Product

Cardiolite / /

Technology

radiopharmaceuticals / /

URL

www.uschamber.com/letter/letter-regarding-ftc-disgorgement / www.ftc.gov/publicstatements/2012/07/statement-commission-regarding-withdrawal-commissions-policy-statement / www.ftc.gov/public-statements/2012/07/statement-commissioner-maureen-kohlhausen-dissenting-commissions-decision / http /

SocialTag